Ramzi, Nurul Hanis
Hoong, Andrew Tan Chun
Johari, Nur Alia
Nathan, Anna Marie
Teh, Cindy Shuan Ju
Sulaiman, Norhayati Aida
Ilias, Mohamad Ikram
Deris, Zakuan Zainy
Hazlan, Siti Nur Haidar
Nasir, Nur Syafiqah Mohamad
Bakar, Asrar Abu
Helmi, Muhd Alwi Muhd
Juhari, Wan Khairunnisa Wan
Kamarudin, Norhidayah
Chong, Chun Wie
Cleary, David W.
Clarke, Stuart C.
Sulaiman, Lokman Hakim
Article History
Received: 4 March 2024
Accepted: 13 August 2024
First Online: 20 August 2024
Declarations
:
: The study protocol, informed consent statement, case report form, any amendments and all other study documents have been submitted to and approved by the institutional ethics committee of each site:
: Not required because no individual identifiers have been included in the manuscript.
: DWC was a post-doctoral researcher on GSK funded projects in 2014/15 and has received grant support from Pfizer and the National Institute for Health via the NIHR Southampton Biomedical Research Centre. LHS and SCC act as principal investigators for clinical trials and other studies conducted on behalf of IMU University, and University Hospital Southampton NHS Foundation Trust/University of Southampton, respectively, that are sponsored by vaccine manufacturers. No personal payments are received from them. SCC has participated in advisory boards for vaccine manufacturers but receives no personal payments for this work. NHR and SCC have received financial assistance from vaccine manufacturers to attend conferences. All grants and honoraria are paid into accounts within the respective IMU University and NHS Trusts or Universities, or to independent charities. All other authors have no conflicts of interest.